A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive AdultsJames E. Moon, Jack Hutter, Karen Ivinson et al.|The Journal of Infectious Diseases|2020Cited by 46
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trialMichael Koren, Kayvon Modjarrad, O.S. Adedeji et al.|The Lancet Infectious Diseases|2023Cited by 23
Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injectionJay W. Hooper, Trevor Wellington, Matthew Josleyn et al.|npj Vaccines|2024Cited by 11
Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trialKayvon Modjarrad, Emmanuel Feroldi, Meshell Morrison et al.|The Lancet Infectious Diseases|2024Cited by 8